False Claims Act - G2 Intelligence

Urine Drug & Genetic Testing Remain Top Enforcement Targets

In an analysis of enforcement actions from the end of 2022 to early spring 2023, cases involving urine drug testing were the most prevalent.

Start a Free Trial for immediate access to this article

Already a member? Log in here

A False Claims Act whistleblower lawsuit can do significant damage to your lab and its reputation, even if the case lacks truth and merit.

Start a Free Trial for immediate access to this article

Already a member? Log in here

In the latest major COVID-19-related enforcement action, 18 individuals were charged in various schemes worth more than $490 million.

Last week’s lone lab-related enforcement action involved a prison sentence for a woman posing as a licensed physician’s assistant.

The DOJ’s 2022 Fraud Statistics Overview shows it raked in less than 50 percent of what it recovered in FY 2021.